MMP9 and systemic lupus erythematosus: Elegant in vitro studies using sera from SLE patients uncovered a mechanism whereby NET formation leads to increased extracellular matrix metalloproteinase (MMP)‐9, which subsequently activates MMP‐2 in endothelial cells leading to increased endothelial cell death and vascular dysfunction (Carmona‐Rivera et al., 2015).